Comencemos

Hay varias opciones que pueden ayudarle a cubrir los gastos de su medicamento de Genentech. Responda a estas preguntas sencillas para averiguar cuál puede ser la adecuada para usted.

  • ¿Tiene seguro médico?

  • ¿Su seguro de salud cubre sus medicamentos de Genentech?

  • ¿Tiene seguro médico comercial?

    ¿Qué significa esto?
  • ¿Está recibiendo alguna ayuda económica para poder pagar el medicamento?

    ¿Qué significa esto?
  • ¿Tiene 18 años de edad o más?

Puede que Reúna los Requisitos para que se le Derive a la Tarjeta de Copago de Genentech BioOncology

PERJETA Access Solutions puede derivarle a la Tarjeta de Copago de Genentech BioOncology. Si reúne los requisitos, puede ayudarle con los costos del bolsillo de su medicamento de Genentech.*

 

Más Información

 

*Para poder optar a la Tarjeta de Copago de Genentech BioOncology, el paciente debe disponer de un seguro comercial, no debe tener Medicare, Medicaid ni ningún otro seguro público y debe cumplir otros criterios de elegibilidad. También debe aceptar las reglas establecidas en los términos y condiciones del programa. Visite CopayAssistanceNow.com para ver la lista completa de términos y condiciones.

Puede que Reúna los Requisitos para que se le Derive a una Fundación Independiente de Asistencia al Copago

Si necesita ayuda con el copago de su medicamento de Genentech, podemos derivarle a una fundación independiente de asistencia al copago.*

 

Más Información

 

*Las fundaciones independientes de asistencia al copago tienen sus propias normas para la elegibilidad. No podemos garantizarle que una fundación le vaya a ayudar. Solo podemos derivarle para que esta le asista con su estado de salud. No respaldamos ni mostramos preferencia económica por ninguna fundación en particular. Las fundaciones a las que le derivemos no son las únicas que pueden ayudarle.

Puede que Reúna los Requisitos para que se le Derive a la Fundación Genentech Patient Foundation

Genentech Patient Foundation proporciona medicamentos gratuitos de Genentech a las personas que no tienen cobertura de seguro o que tienen problemas financieros, y a personas con determinado nivel de ingresos.*

 

Más Información

 

*Si cuenta con cobertura de un seguro médico para su medicamento, primero debe haber probado otros tipos de asistencia a pacientes para ser apto para recibir medicamentos gratis de Genentech a través de Genentech Patient Foundation. Esto incluye la Tarjeta de Copago de Genentech BioOncology y la ayuda de fundaciones independientes de asistencia al copago. También debe cumplir otros criterios financieros. Si no tiene seguro o si su seguro no cubre su medicamento, debe cumplir unos criterios financieros diferentes.

Important Safety Information & Indication

What it Treats

PERJETA® (pertuzumab) is approved for use in combination with Herceptin® (trastuzumab) and chemotherapy for:

  • use prior to surgery (neoadjuvant treatment) in people with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive). PERJETA should be used as part of a complete treatment regimen for early stage breast cancer. 
  • use after surgery (adjuvant treatment) in people with HER2-positive early breast cancer that has a high likelihood of coming back.

PERJETA® is approved for use in combination with Herceptin® and docetaxel in people who have HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-HER2 therapy or chemotherapy for metastatic breast cancer.

Important Safety Information

What should I know about side effects with PERJETA?

  • Not all people have serious side effects; however, side effects with PERJETA therapy are common. It is important to know what side effects may happen and what symptoms you should watch for
  • Your doctor may stop treatment if serious side effects happen. Be sure to contact your healthcare team right away if you have questions or are worried about any side effects

What are the most serious side effects of PERJETA?

PERJETA may cause heart problems, including those without symptoms (such as reduced heart function) and those with symptoms (such as congestive heart failure).

  • Your doctor may run tests to monitor your heart function before and during treatment with PERJETA
  • Based on test results, your doctor may hold or discontinue treatment with PERJETA

Receiving PERJETA during pregnancy can result in the death of an unborn baby and birth defects.

  • Birth control should be used while receiving PERJETA and for 7 months after your last dose of PERJETA. If you are a mother who is breastfeeding, you should talk with your doctor about either stopping breastfeeding or stopping PERJETA
  • If you think you may be pregnant, you should contact your healthcare provider immediately
  • If you are exposed to PERJETA during pregnancy, or become pregnant while receiving PERJETA or within 7 months following the last dose of PERJETA in combination with Herceptin, you are encouraged to enroll in the MotHER Pregnancy Registry by contacting 1-800-690-6720 or visiting http://www.motherpregnancyregistry.com/ and report PERJETA exposure to Genentech at 1-888-835-2555

What are other possible serious side effects?

  • PERJETA should not be used in patients who are allergic to pertuzumab or to any of the ingredients in PERJETA
  • Infusion-related reactions: PERJETA is a medicine that is delivered into a vein through a needle. This process can cause reactions known as infusion-related reactions. The most common infusion-related reactions when receiving PERJETA, Herceptin, and docetaxel were feeling tired, abnormal or altered taste, allergic reactions, muscle pain, and vomiting. The most common infusion-related reactions when receiving PERJETA alone were fever, chills, feeling tired, headache, weakness, allergic reactions, and vomiting
  • Severe allergic reactions: Some people receiving PERJETA may have severe allergic reactions, called hypersensitivity reactions or anaphylaxis. These reactions may be severe, may happen quickly, and may affect many areas of the body

What are the most common side effects?

The most common side effects of PERJETA when given with Herceptin and docetaxel for treatment of breast cancer that has spread to other parts of the body (metastatic) are:

  • Diarrhea
  • Hair loss
  • Low levels of white blood cells with or without fever
  • Nausea
  • Feeling tired
  • Rash
  • Damage to the nerves (numbness, tingling, pain in hands/feet)

The most common side effects of PERJETA when given with Herceptin and docetaxel as part of an early breast cancer regimen before surgery are:

  • Hair loss
  • Low levels of white blood cells with or without fever
  • Diarrhea
  • Nausea

The most common side effects of PERJETA when given with Herceptin and docetaxel following 3 cycles of epirubicin, cyclophosphamide, and fluorouracil as part of an early breast cancer regimen before surgery are:

  • Diarrhea
  • Nausea
  • Hair loss
  • Low levels of white blood cells with or without fever
  • Vomiting
  • Feeling tired

The most common side effects of PERJETA when given with Herceptin, docetaxel, and carboplatin as part of an early breast cancer regimen before surgery are:

  • Diarrhea
  • Hair loss
  • Low levels of white blood cells with or without fever
  • Nausea
  • Feeling tired
  • Vomiting
  • Low levels of red blood cells
  • Low platelet count

The most common side effects of PERJETA when given with Herceptin and paclitaxel following 4 cycles of dose-dense doxorubicin and cyclophosphamide as part of an early breast cancer regimen before surgery are:

  • Nausea
  • Diarrhea
  • Hair loss
  • Feeling tired
  • Constipation
  • Damage to the nerves (numbness, tingling, pain in hands/feet)
  • Headache

The most common side effects of PERJETA when given with Herceptin and docetaxel following 4 cycles of epirubicin, cyclophosphamide, and fluorouracil as part of an early breast cancer regimen before surgery are:

  • Diarrhea
  • Nausea
  • Hair loss
  • Weakness
  • Constipation
  • Feeling tired
  • Mouth blisters or sores
  • Vomiting
  • Pain in the muscles
  • Low levels of red blood cells

The most common side effects of PERJETA when given with Herceptin and chemotherapy as part of an early breast cancer regimen after surgery are:

  • Diarrhea
  • Nausea
  • Hair Loss
  • Feeling tired
  • Damage to the nerves (numbness, tingling, pain in hands/feet)
  • Vomiting

You are encouraged to report side effects to Genentech and the FDA. You may report side effects to the FDA at 1-800FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.

Please see full Prescribing Information for additional Important Safety Information, including most serious side effects